XML 22 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
PAY VERSUS PERFORMANCE
2023 PAY VERSUS PERFORMANCE
Year(1)
​ ​
Summary
Compensation
Table Total
for PEO
($)(2)
​ ​
Compensation
Actually Paid
to PEO
($)(3)
​ ​
Average
Summary
Compensation
Table Total
for Non-PEO
NEOs
($)(2)
​ ​
Average
Compensation
Actually Paid
to Non-PEO
NEOs
($)(3)
​ ​
Value of Initial Fixed $100
Investment Based On:(4)
​ ​
Net
Income
(Loss)
($)
​ ​
Non-GAAP
EBITDA(6)
($)
​
​
Total
Shareholder
Return
($)
​ ​
Peer Group
Total
Shareholder
Return
($)(5)
​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ 4,283,137 ​ ​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ 2,707,080 ​ ​ ​ ​ ​ 46.05 ​ ​ ​ ​ ​ 86.74 ​ ​ ​ ​ ​ (20,371,000) ​ ​ ​ ​ ​ 137,885,000 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (13,263,924) ​ ​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (2,970,567) ​ ​ ​ ​ ​ 61.70 ​ ​ ​ ​ ​ 86.04 ​ ​ ​ ​ ​ 5,648,000 ​ ​ ​ ​ ​ 192,885,000 ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ 23,007,852 ​ ​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ 7,279,179 ​ ​ ​ ​ ​ 220.80 ​ ​ ​ ​ ​ 114.41 ​ ​ ​ ​ ​ 77,849,000 ​ ​ ​ ​ ​ 229,617,000 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ 15,533,481 ​ ​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ 4,029,011 ​ ​ ​ ​ ​ 146.87 ​ ​ ​ ​ ​ 127.18 ​ ​ ​ ​ ​ 32,194,000 ​ ​ ​ ​ ​ 159,388,000 ​ ​
​
(1)
Mr. Lipps served as the Company’s principal executive officer for the entirety of 2020, 2021, 2022 and 2023, and the Company’s other NEOs for the applicable years were as follows:
​
2023: Nchacha E. Etta; Corey J. Manley; Peter J. Kuipers; Scott P. Seidelmann; and Christine Mellon.
2022: Peter J. Kuipers; Scott P. Seidelmann; Christine Mellon, Corey J. Manley and Dan S. Johnston.
2021: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Christine Mellon.
2020: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Nhat H. Ngo.
(2)
Amounts reported in this column represent (i) the total compensation reported in the Summary Compensation Table for the applicable year in the case of Mr. Lipps and (ii) the average of the total compensation reported in the Summary Compensation Table for the applicable year for the Company’s NEOs reported for the applicable year other than Mr. Lipps.
​
(3)
To calculate compensation actually paid, adjustments were made to the amounts reported in the Summary Compensation Table for the applicable year. A reconciliation of the adjustments for Mr. Lipps and for the average of the other NEOs is set forth following the footnotes to this table.
​
(4)
Pursuant to rules of the SEC, the comparison assumes $100 was invested on December 31, 2019. Historic stock price performance is not indicative of future stock price performance.
​
(5)
The TSR Peer Group consists of the NASDAQ Health Care Index, an independently prepared index that includes companies in the healthcare industry.
​
(6)
As noted in the CD&A, for 2023, the Compensation Committee determined that non-GAAP EBITDA is a core driver of the Company’s performance and stockholder value creation and, accordingly, was utilized as a component for the annual performance-based cash bonus awards. Under the annual performance-based cash bonus awards, non-GAAP EBITDA for incentive purposes is defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation expenses pursuant to ASC Topic 718, as well as excluding certain other non-GAAP adjustments such as acquisition-related expenses, executive transition costs, severance-related expenses, and other items that the Compensation Committee determined were unusual, non-recurring or not reflective of normal operations.
​
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
​
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
​
(i)
See footnote 1 above for the NEOs included in the average for each year.
     
Company Selected Measure Name Non-GAAP EBITDA      
Named Executive Officers, Footnote
(1)
Mr. Lipps served as the Company’s principal executive officer for the entirety of 2020, 2021, 2022 and 2023, and the Company’s other NEOs for the applicable years were as follows:
​
2023: Nchacha E. Etta; Corey J. Manley; Peter J. Kuipers; Scott P. Seidelmann; and Christine Mellon.
2022: Peter J. Kuipers; Scott P. Seidelmann; Christine Mellon, Corey J. Manley and Dan S. Johnston.
2021: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Christine Mellon.
2020: Peter J. Kuipers; Scott P. Seidelmann; Dan S. Johnston; and Nhat H. Ngo.
     
Peer Group Issuers, Footnote
(5)
The TSR Peer Group consists of the NASDAQ Health Care Index, an independently prepared index that includes companies in the healthcare industry.
     
PEO Total Compensation Amount $ 11,022,072 $ 7,902,397 $ 8,437,413 $ 8,028,508
PEO Actually Paid Compensation Amount $ 4,283,137 (13,263,924) 23,007,852 15,533,481
Adjustment To PEO Compensation, Footnote
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
​
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
​
(i)
See footnote 1 above for the NEOs included in the average for each year.
     
Non-PEO NEO Average Total Compensation Amount $ 2,960,737 2,420,898 3,380,842 2,250,868
Non-PEO NEO Average Compensation Actually Paid Amount $ 2,707,080 (2,970,567) 7,279,179 4,029,011
Adjustment to Non-PEO NEO Compensation Footnote
Compensation Actually Paid Adjustments
​ ​ ​ ​ ​ ​ ​ ​ ​
Minus
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Plus
​ ​
Plus/(Minus)
​ ​
Minus
​ ​
Plus
​ ​
Equals
​
Year
​ ​
Summary
Compensation
Table Total
($)(a)
​ ​
Grant
Date Fair
Value of
Stock
Option
and Stock
Awards
Granted
in Fiscal
Year
($)(b)
​ ​
Fair Value
at Fiscal
Year-End of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Fiscal Year
($)(c)
​ ​
Change in
Fair
Value of
Outstanding
and
Unvested
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years
($)(d)
​ ​
Fair
Value at
Vesting
of Stock
Option
and Stock
Awards
Granted
in Fiscal
Year that
Vested
During
Fiscal
Year
($)(e)
​ ​
Change in
Fair Value
as of Vesting
Date of
Stock
Option and
Stock
Awards
Granted in
Prior Fiscal
Years for
which
Applicable
Vesting
Conditions
Were
Satisfied
During
Fiscal Year
($)(f)
​ ​
Fair Value
as of Prior
Fiscal Year-
End of
Stock
Option and
Stock Awards
Granted in
Prior Fiscal
Years that
Failed to
Meet
Applicable
Vesting
Conditions
During
Fiscal Year
($)(g)
​ ​
Changes in
Fair Value to
Reflect
Excess Fair
Value
Resulting
From
Modifications
to Stock
Option and
Stock Awards
($)(h)
​ ​
Compensation
Actually Paid
​
Randall A. Lipps ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 11,022,072 ​ ​ ​ ​ ​ (9,174,870) ​ ​ ​ ​ ​ 3,031,350 ​ ​ ​ ​ ​ (312,629) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 164,437 ​ ​ ​ ​ ​ (447,223) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,283,137 ​ ​
2022
​ ​ ​ ​ 7,902,397 ​ ​ ​ ​ ​ (6,699,022) ​ ​ ​ ​ ​ 1,328,514 ​ ​ ​ ​ ​ (8,414,632) ​ ​ ​ ​ ​ 470,595 ​ ​ ​ ​ ​ (7,851,777) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (13,263,924) ​ ​
2021
​ ​ ​ ​ 8,437,413 ​ ​ ​ ​ ​ (6,001,550) ​ ​ ​ ​ ​ 10,175,965 ​ ​ ​ ​ ​ 5,991,052 ​ ​ ​ ​ ​ 830,085 ​ ​ ​ ​ ​ 3,574,887 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 23,007,852 ​ ​
2020
​ ​ ​ ​ 8,028,508 ​ ​ ​ ​ ​ (6,050,819) ​ ​ ​ ​ ​ 9,040,517 ​ ​ ​ ​ ​ 4,238,153 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 277,122 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 15,533,481 ​ ​
Other NEOs(i) ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
2023
​ ​ ​ ​ 2,960,737 ​ ​ ​ ​ ​ (1,404,150) ​ ​ ​ ​ ​ 1,408,170 ​ ​ ​ ​ ​ (43,870) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 72,948 ​ ​ ​ ​ ​ (402,639) ​ ​ ​ ​ ​ 115,884 ​ ​ ​ ​ ​ 2,707,080 ​ ​
2022
​ ​ ​ ​ 2,420,898 ​ ​ ​ ​ ​ (1,879,383) ​ ​ ​ ​ ​ 326,852 ​ ​ ​ ​ ​ (1,698,012) ​ ​ ​ ​ ​ 131,140 ​ ​ ​ ​ ​ (1,607,035) ​ ​ ​ ​ ​ (665,026) ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ (2,970,567) ​ ​
2021
​ ​ ​ ​ 3,380,842 ​ ​ ​ ​ ​ (2,374,967) ​ ​ ​ ​ ​ 3,930,801 ​ ​ ​ ​ ​ 1,229,594 ​ ​ ​ ​ ​ 363,110 ​ ​ ​ ​ ​ 749,800 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 7,279,179 ​ ​
2020
​ ​ ​ ​ 2,250,868 ​ ​ ​ ​ ​ (1,355,693) ​ ​ ​ ​ ​ 1,837,660 ​ ​ ​ ​ ​ 1,127,068 ​ ​ ​ ​ ​ 101,699 ​ ​ ​ ​ ​ 67,408 ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ — ​ ​ ​ ​ ​ 4,029,011 ​ ​
​
(a)
Represents Total Compensation as reported in the Summary Compensation Table for the indicated fiscal year. With respect to the other NEOs, amounts shown represent averages.
​
(b)
Represents the grant date fair value of the stock option and stock awards granted during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(c)
Represents the fair value as of the indicated fiscal year-end of the outstanding and unvested option awards and stock awards granted during such fiscal year, computed in accordance with the methodology used for financial reporting purposes and, in the case of awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the applicable date.
​
(d)
Represents the change in fair value during the indicated fiscal year of each option award and stock award that was granted in a prior fiscal year and that remained outstanding and unvested as of the last day of the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes and, for awards subject to performance-based vesting conditions, based on the probable outcome of such performance-based vesting conditions as of the last day of the fiscal year.
​
(e)
Represents the fair value at vesting of the option awards and stock awards that were granted and vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(f)
Represents the change in fair value, measured from the prior fiscal year-end to the vesting date, of each option award and stock award that was granted in a prior fiscal year and which vested during the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(g)
Represents the fair value as of the last day of the prior fiscal year of the option award and stock awards that were granted in a prior fiscal year and which failed to meet the applicable vesting conditions in the indicated fiscal year, computed in accordance with the methodology used for financial reporting purposes.
​
(h)
Represents the excess fair value, if any, of modified option awards over the fair value of the original awards as of the modification and which are not otherwise reflected in the other columns in this table.
​
(i)
See footnote 1 above for the NEOs included in the average for each year.
     
Compensation Actually Paid vs. Total Shareholder Return [MISSING IMAGE: lc_ttlshrholret-bw.jpg]      
Compensation Actually Paid vs. Net Income
[MISSING IMAGE: lc_netincome-bw.jpg]
     
Compensation Actually Paid vs. Company Selected Measure
[MISSING IMAGE: lc_ebitda-bw.jpg]
     
Total Shareholder Return Vs Peer Group [MISSING IMAGE: lc_ttlshrholret-bw.jpg]      
Tabular List, Table
Performance Measures Used to Link Company Performance and Compensation Actually Paid to the NEOs
Below is a list of performance measures, which in the Company’s assessment represent the most important performance measures used by the Company to link compensation actually paid to the NEOs for 2023. Please see the CD&A for further information regarding how each of these measures is used in the Company’s executive compensation program.
•
Non-GAAP EBITDA
​
•
Advanced Services Revenue
​
•
Free Cash Flow
​
•
Total Revenue
​
•
Operational Expenditures
​
•
Relative Total Shareholder Return
​
•
Stock Price
​
​
      
Total Shareholder Return Amount $ 46.05 61.7 220.8 146.87
Peer Group Total Shareholder Return Amount 86.74 86.04 114.41 127.18
Net Income (Loss) $ (20,371,000) $ 5,648,000 $ 77,849,000 $ 32,194,000
Company Selected Measure Amount 137,885,000 192,885,000 229,617,000 159,388,000
PEO Name Mr. Lipps      
Measure:: 1        
Pay vs Performance Disclosure        
Name Non-GAAP EBITDA      
Non-GAAP Measure Description
(6)
As noted in the CD&A, for 2023, the Compensation Committee determined that non-GAAP EBITDA is a core driver of the Company’s performance and stockholder value creation and, accordingly, was utilized as a component for the annual performance-based cash bonus awards. Under the annual performance-based cash bonus awards, non-GAAP EBITDA for incentive purposes is defined as earnings before interest income and expense, taxes, depreciation, amortization, and share-based compensation expenses pursuant to ASC Topic 718, as well as excluding certain other non-GAAP adjustments such as acquisition-related expenses, executive transition costs, severance-related expenses, and other items that the Compensation Committee determined were unusual, non-recurring or not reflective of normal operations.
     
Measure:: 2        
Pay vs Performance Disclosure        
Name Advanced Services Revenue      
Measure:: 3        
Pay vs Performance Disclosure        
Name Free Cash Flow      
Measure:: 4        
Pay vs Performance Disclosure        
Name Total Revenue      
Measure:: 5        
Pay vs Performance Disclosure        
Name Operational Expenditures      
Measure:: 6        
Pay vs Performance Disclosure        
Name Relative Total Shareholder Return      
Measure:: 7        
Pay vs Performance Disclosure        
Name Stock Price      
PEO | Equity Awards Value In Summary Compensation Table (Grant Date Value)        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (9,174,870) $ (6,699,022) $ (6,001,550) $ (6,050,819)
PEO | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 3,031,350 1,328,514 10,175,965 9,040,517
PEO | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (312,629) (8,414,632) 5,991,052 4,238,153
PEO | Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 470,595 830,085
PEO | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 164,437 (7,851,777) 3,574,887 277,122
PEO | Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (447,223)
PEO | Changes in Fair Value to Reflect Excess Fair Value Resulting From Modifications to Stock Option and Stock Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount
Non-PEO NEO | Equity Awards Value In Summary Compensation Table (Grant Date Value)        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (1,404,150) (1,879,383) (2,374,967) (1,355,693)
Non-PEO NEO | Year-end Fair Value Of Awards Granted In The Current Fiscal Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,408,170 326,852 3,930,801 1,837,660
Non-PEO NEO | Change In Fair Value Of Outstanding And Unvested Awards Granted In Prior Fiscal Years [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (43,870) (1,698,012) 1,229,594 1,127,068
Non-PEO NEO | Change In Fair Value As Of Vesting Date Of Current Year Awards Vested During Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 131,140 363,110 101,699
Non-PEO NEO | Change In Fair Value As Of Vesting Date Of Prior Year Awards Vested During Current Year [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 72,948 (1,607,035) 749,800 67,408
Non-PEO NEO | Adjustments For Equity Awards Failed To Meet Performance Conditions [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (402,639) (665,026)
Non-PEO NEO | Changes in Fair Value to Reflect Excess Fair Value Resulting From Modifications to Stock Option and Stock Awards [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 115,884